22nd Century Group, Inc.

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, PM has a market cap of 245B. Regarding current trading prices, XXII is priced at $2.21, while PM trades at $157.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas PM's P/E ratio is 21.67. In terms of profitability, XXII's ROE is -0.44%, compared to PM's ROE of -1.04%. Regarding short-term risk, XXII is more volatile compared to PM. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check PM's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, BTI has a market cap of 126.1B. Regarding current trading prices, XXII is priced at $2.21, while BTI trades at $57.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas BTI's P/E ratio is 12.53. In terms of profitability, XXII's ROE is -0.44%, compared to BTI's ROE of +0.16%. Regarding short-term risk, XXII is more volatile compared to BTI. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check BTI's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, MO has a market cap of 109.9B. Regarding current trading prices, XXII is priced at $2.21, while MO trades at $65.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas MO's P/E ratio is 15.89. In terms of profitability, XXII's ROE is -0.44%, compared to MO's ROE of -2.15%. Regarding short-term risk, XXII is more volatile compared to MO. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check MO's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, RLX has a market cap of 2.7B. Regarding current trading prices, XXII is priced at $2.21, while RLX trades at $2.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas RLX's P/E ratio is 21.85. In terms of profitability, XXII's ROE is -0.44%, compared to RLX's ROE of +0.06%. Regarding short-term risk, XXII is more volatile compared to RLX. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check RLX's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, VGR has a market cap of 2.4B. Regarding current trading prices, XXII is priced at $2.21, while VGR trades at $14.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas VGR's P/E ratio is 11.90. In terms of profitability, XXII's ROE is -0.44%, compared to VGR's ROE of -0.24%. Regarding short-term risk, XXII is more volatile compared to VGR. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check VGR's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, TPB has a market cap of 1.4B. Regarding current trading prices, XXII is priced at $2.21, while TPB trades at $74.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas TPB's P/E ratio is 23.87. In terms of profitability, XXII's ROE is -0.44%, compared to TPB's ROE of +0.21%. Regarding short-term risk, XXII is less volatile compared to TPB. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check TPB's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, UVV has a market cap of 1.3B. Regarding current trading prices, XXII is priced at $2.21, while UVV trades at $52.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas UVV's P/E ratio is 15.43. In terms of profitability, XXII's ROE is -0.44%, compared to UVV's ROE of +0.06%. Regarding short-term risk, XXII is more volatile compared to UVV. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check UVV's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, ISPR has a market cap of 99.1M. Regarding current trading prices, XXII is priced at $2.21, while ISPR trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas ISPR's P/E ratio is -2.79. In terms of profitability, XXII's ROE is -0.44%, compared to ISPR's ROE of -23.84%. Regarding short-term risk, XXII is less volatile compared to ISPR. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check ISPR's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, VAPE has a market cap of 15M. Regarding current trading prices, XXII is priced at $2.21, while VAPE trades at $17.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas VAPE's P/E ratio is -4.22. In terms of profitability, XXII's ROE is -0.44%, compared to VAPE's ROE of -0.26%. Regarding short-term risk, XXII is less volatile compared to VAPE. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check VAPE's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, GNLN has a market cap of 435.6K. Regarding current trading prices, XXII is priced at $2.21, while GNLN trades at $0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas GNLN's P/E ratio is N/A. In terms of profitability, XXII's ROE is -0.44%, compared to GNLN's ROE of -2.80%. Regarding short-term risk, XXII is less volatile compared to GNLN. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check GNLN's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, KAVL has a market cap of 176.2K. Regarding current trading prices, XXII is priced at $2.21, while KAVL trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas KAVL's P/E ratio is -0.01. In terms of profitability, XXII's ROE is -0.44%, compared to KAVL's ROE of -2.47%. Regarding short-term risk, XXII is more volatile compared to KAVL. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check KAVL's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, VAPEW has a market cap of 147.9K. Regarding current trading prices, XXII is priced at $2.21, while VAPEW trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas VAPEW's P/E ratio is N/A. In terms of profitability, XXII's ROE is -0.44%, compared to VAPEW's ROE of +0.79%. Regarding short-term risk, XXII is less volatile compared to VAPEW. This indicates potentially lower risk in terms of short-term price fluctuations for XXII.Check VAPEW's competition here

XXII plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, XXII stands at 362.2K. In comparison, RAI has a market cap of 0. Regarding current trading prices, XXII is priced at $2.21, while RAI trades at $65.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

XXII currently has a P/E ratio of -0.02, whereas RAI's P/E ratio is N/A. In terms of profitability, XXII's ROE is -0.44%, compared to RAI's ROE of +0.30%. Regarding short-term risk, XXII is more volatile compared to RAI. This indicates potentially higher risk in terms of short-term price fluctuations for XXII.Check RAI's competition here